Most researches of cancer precision medicine are only confined to the patients that have been included in clinical tests. Few researches evaluate how doctors in daily life use biomarkers to recommend chemotherapy or decide the treatment scheme for the patients. Today, we will talk about a research published on the journal Cancer, which has disclosed how in daily life precision medicine improves the treatment of cancer.

October of each year is the "World's Month for Prevention and Control of Breast Cancer", which is also called "Pink Ribbon Month". Breast cancer is the commonest cancer among women, as well as "No.2 killer" for the death of women, only after lung cancer. To enhance the awareness of the public in breast cancer, various publicity activities will be staged in this period across the world. Earlier, famous architectures such as White House, Tokyo Tower and Burj Dubai have put on a pink outfit in succession to appeal the public to pay more attention to breast cancer.

Recently, with a kind of virus researchers have imported a specific gene into the brain to stop the worsening of senile dementia in small mice. This research was sponsored by Alzheimer's Research UK and European Research Council. Related research results were published on the journal PNAS on October 10.

The trend of cancer treatment is targeted individualized medical treatment. On the Medical Diagnosis Conference held in Xiamen recently, experts pointed out that "auxiliary diagnosis" and "targeted treatment" are two most important tools for individualized precise treatment of tumor. Compared with chemotherapy, auxiliary diagnosis can better enhance the survival rate of some patient groups, improve the treatment prognosis and reduce the healthcare expenditure.